Continuing Care App for Probationers and Parolees with Substance Use Disorders
Continuing Care App for Probationers and Parolees with Substance Use Disorders
批准号:
8997778
负责人:
Michael Scott Gordon
金额:
$16.99万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-07-28 至 2017-12-31
关键词:
AODD relapseAbstinenceAcuteAdultAfrican AmericanAftercareAlcohol or Other Drugs useAppleAreaBaltimoreCaringCellular PhoneChronicChronic DiseaseClientCognitive TherapyCollaborationsCommunitiesCommunity Health CentersComorbidityCriminal JusticeDataData AnalysesDevelopmentDiffusionDisadvantagedDisease modelDrug AddictionDrug abuseDrug usageFederally Qualified Health CenterFeedbackFeesFocus GroupsGenetic TranscriptionGlosso-SterandrylHIVHIV InfectionsHIV riskHealthHealth PersonnelHealthcareHigh PrevalenceImprisonmentIndividualInternetInterventionLicensingLifeLow incomeMarketingMarylandMinorityModelingNeighborhoodsOutpatientsParticipantPharmaceutical PreparationsPhasePopulationPovertyProfessional counselorPublic HealthQuestionnairesRecording of previous eventsRecoveryRelapseResearchResearch InfrastructureRiskRisk BehaviorsRisk FactorsSamplingSelf ManagementServicesSmall Business Technology Transfer ResearchStagingSubstance Use DisorderSubstance abuse problemSupervisionSystemTarget PopulationsTechnologyTestingUnemploymentaddictionbasebehavior changecare systemscriminal behaviorcriminal thinkingdesignexperiencehealth disparityhigh riskimprovedinner cityinnovationmobile applicationparoleparoleeprobationprobationerprogramsprototypepublic health relevanceracial disparitysexsubstance abuse treatmenttheoriestooltreatment durationusabilityweek trial
中文摘要
英文摘要
DESCRIPTION (provided by applicant): Substance use disorders (SUDs) continue to be one of the most serious public health problems in the US. Studies have consistently documented a substantially higher prevalence of SUDs among individuals under criminal justice supervision. At year-end 2013, approximately 4.75 million adults were on probation or parole (1 in 51 adults). African American probationers and parolees with SUDs are particularly vulnerable to illicit substance use and HIV infection as they typically live in neighborhoods characterized by high rates of joblessness, drug use, and poverty and they are likely to engage in drug-and sex-related HIV risk behaviors in the community. Studies have shown that continuing care interventions have been found to extend primary treatment gains with respect to reductions in substance use, relapse, and criminal activity. We propose to develop a continuing care mobile application for probationers and parolees completing substance abuse treatment who are at high risk of substance abuse relapse, HIV related risk factors, and re-arrest and re- incarceration. Probationers and parolees, many of whom are low-income urban African Americans, are an important health disparity population that stands to benefit from continuing care technologies. This research will be conducted in collaboration with Total Health Care (THC), a federally qualified health center and Maryland's largest minority-operated non-profit community health center. If found effective, the proposed application could be deployed across the national network of outpatient substance abuse treatment providers/programs, potentially improving the dissemination of continuing care services outside of traditional systems of care and be highly significant in its direct impact on public health for individuals involved in the criminal justice system.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Long-acting naltrexone for pre-release prisoners: A randomized trial of mobile treatment
-
批准号:10738933
-
项目类别:
-
资助金额:$44.41万
-
财政年份:2023
-
负责人:Michael Scott Gordon
-
依托单位:
A comparative effectiveness trial of extended release naltrexone versus extended-release buprenorphine with individuals leaving jail
-
批准号:10160255
-
项目类别:
-
资助金额:$16.54万
-
财政年份:2019
-
负责人:Michael Scott Gordon
-
依托单位:
A comparison of Sublingual and Extended-Release Buprenorphine for Individuals Leaving Jail
-
批准号:10547922
-
项目类别:
-
资助金额:$67.86万
-
财政年份:2019
-
负责人:Michael Scott Gordon
-
依托单位:
A comparative effectiveness trial of extended release naltrexone versus extended-release buprenorphine with individuals leaving jail
-
批准号:10616501
-
项目类别:
-
资助金额:$196.71万
-
财政年份:2019
-
负责人:Michael Scott Gordon
-
依托单位:
A comparative effectiveness trial of extended release naltrexone versus extended-release buprenorphine with individuals leaving jail
-
批准号:10388285
-
项目类别:
-
资助金额:$216.94万
-
财政年份:2019
-
负责人:Michael Scott Gordon
-
依托单位:
A comparative effectiveness trial of extended release naltrexone versus extended-release buprenorphine with individuals leaving jail
-
批准号:9978020
-
项目类别:
-
资助金额:$223.15万
-
财政年份:2019
-
负责人:Michael Scott Gordon
-
依托单位:
Buprenorphine for probationers and parolees: Bridging the gap into treatment
-
批准号:9898338
-
项目类别:
-
资助金额:$62.84万
-
财政年份:2018
-
负责人:Michael Scott Gordon
-
依托单位:
Buprenorphine for probationers and parolees: Bridging the gap into treatment
-
批准号:10610309
-
项目类别:
-
资助金额:$56.27万
-
财政年份:2018
-
负责人:Michael Scott Gordon
-
依托单位:
Buprenorphine for probationers and parolees: Bridging the gap into treatment
-
批准号:9900629
-
项目类别:
-
资助金额:$59.94万
-
财政年份:2018
-
负责人:Michael Scott Gordon
-
依托单位:
Long-acting naltrexone for pre-release prisoners: A randomized trial of mobile treatment
-
批准号:9689961
-
项目类别:
-
资助金额:$63.78万
-
财政年份:2016
-
负责人:Michael Scott Gordon
-
依托单位:
A Randomized Controlled Trial and Cohort Study of HIV Testing and Linkage to Care
-
批准号:8142894
-
项目类别:
-
资助金额:$73.16万
-
财政年份:2010
-
负责人:Michael Scott Gordon
-
依托单位:
A Randomized Controlled Trial and Cohort Study of HIV Testing and Linkage to Care
-
批准号:8490329
-
项目类别:
-
资助金额:$65.47万
-
财政年份:2010
-
负责人:Michael Scott Gordon
-
依托单位:
A Randomized Controlled Trial and Cohort Study of HIV Testing and Linkage to Care
-
批准号:8667413
-
项目类别:
-
资助金额:$40.06万
-
财政年份:2010
-
负责人:Michael Scott Gordon
-
依托单位:
A Randomized Controlled Trial and Cohort Study of HIV Testing and Linkage to Care
-
批准号:8287041
-
项目类别:
-
资助金额:$68.51万
-
财政年份:2010
-
负责人:Michael Scott Gordon
-
依托单位:
Treatment Study Using Depot Naltrexone(5/6)Baltimore Protocol Treatment Site
-
批准号:8262395
-
项目类别:
-
资助金额:$20.05万
-
财政年份:2008
-
负责人:Michael Scott Gordon
-
依托单位:
海外基金